Yerong R. Yu
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Association between vertebral fracture risk and bone mineral density in patients with acromegaly.
Journal: Pituitary
Published: September 02, 2025
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4, a novel once-weekly basal insulin, in healthy participants: A randomized trial.
Journal: Diabetes, obesity & metabolism
Published: February 20, 2025
Evaluation of pharmacokinetic and pharmacodynamic similarity of an IDegAsp biosimilar versus the originator in healthy Chinese volunteers.
Journal: Expert opinion on investigational drugs
Published: February 11, 2025
Evaluation of Pharmacokinetics and Safety of the Biosimilar (B01711) and Insulin Degludec/Insulin Aspart (IDegAsp, Ryzodeg) in Healthy Chinese Adults in a Randomized, Open-Label, Single-Dose, Crossover, Phase I Study.
Journal: Drug design, development and therapy
Published: November 11, 2024
Oncocytic pituicytoma in a patient with Cushing's disease: a case report and narrative literature review.
Journal: Frontiers in endocrinology
Published: August 27, 2024
Osilodrostat treatment in patients with Cushing's disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4).
Journal: Endocrine journal
Published: August 25, 2024
Diagnosis and Management of Aggressive/Refractory Growth Hormone-Secreting Pituitary Neuroendocrine Tumors.
Journal: International journal of endocrinology
Published: December 26, 2023
Retraction: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites.
Journal: RSC advances
Published: December 18, 2023
A phase-I randomized euglycemic clamp study to demonstrate the pharmacokinetic and pharmacodynamic equivalence of an insulin degludec biosimilar (B01411) with the reference product in healthy Chinese volunteers.
Journal: Expert opinion on investigational drugs
Published: September 04, 2023
Predictive factors and the management of hyperglycemia in patients with acromegaly and Cushing's disease receiving pasireotide treatment: post hoc analyses from the SOM230B2219 study.
Journal: Frontiers in endocrinology
Published: June 30, 2023
Last Updated: 09/26/2026